Products and Services:

Based on their website, TargetRx's offerings likely encompass various stages of the biopharmaceutical development process. This potentially includes:

• Research and Development: Conducting pre-clinical and clinical studies to develop new therapies.
• Manufacturing: Production of biopharmaceutical products, possibly through collaborations or in-house facilities.
• Commercialization: Marketing and distribution of developed therapies to the market.

The exact nature and scope of these activities require further investigation beyond publicly available information.

Company Mission and Values (Inferred from Website):

TargetRx appears dedicated to advancing healthcare through scientific innovation and the development of high-quality biopharmaceutical products. A strong emphasis on research and development suggests a commitment to pushing the boundaries of scientific understanding to improve patient outcomes. Further details regarding specific company values would necessitate accessing internal documentation or engaging with company representatives.

Company Size and Structure:

The precise size and organizational structure of TargetRx are not explicitly provided on their English website. Further research into Chinese business registries or industry databases would be required to obtain this information.

Conclusion:

Shenzhen Tajirui Biopharmaceutical Co., operating under the name TargetRx, presents itself as a significant player within the Chinese biopharmaceutical landscape. While the publicly accessible information is limited, the company's focus on research, development, and commercialization highlights its commitment to innovation and improving healthcare. More detailed information about specific projects, partnerships, and financial performance would require access to additional resources not readily available.